The current S&P 500 P/E ratio is 26.57 (as of 2/24/17, end of day) – to compare with a mean P/E of 15.64 and median of 14.65 (sample data since 1870). Stocks are quite expensive – but we are NOT in a bubble, not yet anyhow, although we’re getting closer…
Current S&P 500 PE Ratio:  26.57 +0.04 (0.15%)
(4:10 pm EST, Fri Feb 24)


Mean: 15.64  since 1870
Median: 14.65  since 1870
Min: 5.31 (Dec 1917)
Max: 123.73 (May 2009)

Price to earnings ratio, based on trailing twelve month “as reported” earnings.
Current PE is estimated from latest reported earnings and current market price.
No matter what – US rate hikes, global growth concerns, the volatility of oil and other commodities, Russia and China’s military ambitions, cybersecurity threats, terrorist attacks, etc. – great companies will continue to thrive. If you are a long-term investor, buy opportunities are out there. Examples? Some energy issues (despite the sector’s recent advance) are still reasonably priced. No wonder Warren Buffett a few months back added to his Phillips 66 (PSX) holdings (at a price close to current ones). Some biotech and healthcare issues seem to present investors with long-term appreciation potential. Think McKesson Corporation (MCK), Biogen (BIIB) (An insider bought a massive amount of BIIB on 10/22 and 10/23/2015; shares still trade in the vicinity), Gilead Sciences, Inc. (GILD), Alnylam Pharmaceuticals (ALNY), AbbVie Inc (ABBV), Mallinckrodt PLC (MNK), Alexion Pharmaceuticals, Inc. (ALXN), and a few others. Financials may need to consolidate after their recent advance, but some retailers may also offer value. Think Bed Bath & Beyond Inc. (BBBY), J C Penney Company Inc (JCP), Macy’s, Inc. (M); just beware of value traps. Casino equities led by Wynn Resorts (WYNN) (which has consolidated over the past few months) may restart to outperform (after underperforming for years). Also intriguing at current valuations: Icahn Enterprises LP (IEP) (Carl Icahn just bought more…), Twitter Inc (TWTR) (Jack Dorsey added to his stake), Stericycle Inc (SRCL), and Transocean LTD (RIG). Please, see below and our daily updates for insiders and hedge funds’ takes and many more ideas…


Shareholders beware!


Updated at 3:22 pm EST, February 25, 2017

If money does not make you happy, give it back.

Jules Renard

If the market goes down, stocks are less expensive and…

A better deal.

Recently or earlier this year insiders have bought shares of (newly added today) Icahn Enterprises LP (IEP), Arconic Inc (ARNC), Blackrock 2022 Global Income Opportunity Trust (BGIO), Evoke Pharma Inc (EVOK), Avon Products, Inc. (AVP), GNC Holdings Inc (GNC), BioTime, Inc. (BTX), Foundation Building Materials, Inc. (FBM), Coty Inc (COTY), Vermillion, Inc. (VRML), Rent-A-Center Inc (RCII), Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc. (SRRA), Colliers International Group Inc (CIGI), Agilysys, Inc. (AGYS), Clipper Realty Inc. (CLPR), Global Water Resources Inc (GWRS), Mallinckrodt PLC (MNK), Aldeyra Therapeutics Inc (ALDX), Vista Outdoor Inc (VSTO), Versants Inc (VSAR), Murphy USA Inc (MUSA), AMC Entertainment Holdings Inc (AMC), Walgreens Boots Alliance Inc (WBA), CONSOL Energy Inc. (CNX), Crispr Therapeutics AG (CRSP), Enterprise Products Partners L.P. (EPD), Murphy USA Inc (MUSA), QUALCOMM, Inc. (QCOM), Envirostar Inc (EVI), Macquarie Infrastructure Corp (MIC), Howard Bancorp Inc (HBMD), Jounce Therapeutics Inc (JNCE), Tailored Brands Inc (TLRD), Live Oak Bancshares Inc (LOB), Seritage Growth Properties (SRG), AnaptysBio Inc (ANAB), Calamos Asset Management, Inc (CLMS), Alliance Data Systems Corporation (ADS), Eagle Bulk Shipping Inc (EGLE), Swift Transportation Co (SWFT), Mirati Therapeutics, Inc. (MRTX), Heron Therapeutics Inc (HRTX), Dell Technologies Inc (DVMT), Kindred Biosciences Inc (KIN), Virtu Financial Inc (VIRT), American Outdoor Brands Corporation, formerly Smith & Wesson Holding Corporation (AOBC), Lawson Products, Inc. (LAWS), WPX Energy Inc (WPX), Seritage Growth Properties (SRG), Regeneron Pharmaceuticals Inc (REGN), Retractable Technologies, Inc. (RVP).


(The aforementioned list only includes a subset of companies where insider purchases have taken place; it is pre-screened by our in-house team of .o3 analysts along criteria that have yet to be determined!) 




Updated at 3:13 pm EST, February 25, 2017

We at FUNanc!al do not provide advice or sell mutual funds or act as brokers of any sort.
Rather we mean to educate a bit and entertain a lot!!!
Investing is not just about compounding or making money (although we like that part too).
It’s about discovering incredible ideas, incredible products, incredible people.
Capitalizing the innovation throughput, financing ventures and fueling growth and the economy.
It’s about seeing the world with a different lens. A new lens.
Feeling like pioneers all over again and having lots of fun in the process. 
Welcome to our site and enjoy with hardly any soupcon of moderation!

I love the bottom line – nearly as much in business as on a woman.

Frederic Marsanne


If money does not make you happy, give it back.

Jules Renard


October. This is one of the peculiarly dangerous months to speculate in stocks. The others are July, January, September, April, November, May, March, June, December, August, and February.

Mark Twain


The more the market slumps, the less it makes sense to sell and the more it makes sense to buy; stocks are less expensive.

The FUnanc!al Team


If things are not failing, you are not innovating enough.

Elon Musk


Crises are opportunities True in the stock market. True in life.

The best investments start with a big scare…

The FUNanc!al Team


"Deadly Investment Sin No. 1: Believing that you have to predict the market's next move to make big returns."


"Reality: Highly successful investors are no better at predicting the market's next move than you or I."


Mark Tier, Author

Becoming Rich

The Wealth-Building Secrets of the World’s Master Investors

Buffett, Icahn, Soros